Reata Pharmaceuticals RETA reported its Q2 earnings results on Monday, August 8, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Reata Pharmaceuticals beat estimated earnings by 32.67%, reporting an EPS of $-1.36 versus an estimate of $-2.02.
Revenue was down $1.46 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.82 which was followed by a 7.0% drop in the share price the next day.
Here's a look at Reata Pharmaceuticals's past performance:
|Quarter||Q1 2022||Q4 2021||Q3 2021||Q2 2021|
To track all earnings releases for Reata Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.